BAYERCROP
Bayer Cropscience Limited
Bayer Cropscience Limited (BAYERCROP) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
bayer.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Bayer Cropscience Limited (NSE: BAYERCROP) is classified in WealthOS's industry taxonomy under Pesticides & Agrochemicals.
Company snapshot
4thBy market cap
Ranked among 23 companies in Pesticides & Agrochemicals.
What we see
- ✓91% of operating profit came in as cash over the last three years — profits are backed by real cash.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,617 Cr | 955 Cr | 792 Cr | 1,631 Cr | 1,738 Cr | 1,057 Cr | 1,046 Cr | 1,915 Cr | 1,553 Cr | 1,106 Cr | 1,101 Cr | 1,835 Cr |
| Operating expenses (approx.) | 1,312 Cr | 827 Cr | 695 Cr | 1,317 Cr | 1,554 Cr | 1,037 Cr | 876 Cr | 1,566 Cr | 1,348 Cr | 989 Cr | 898 Cr | 1,467 Cr |
| EBITDA | 305 Cr | 128 Cr | 97 Cr | 314 Cr | 184 Cr | 20 Cr | 171 Cr | 348 Cr | 205 Cr | 117 Cr | 203 Cr | 368 Cr |
| OPM % | 18.9% | 13.4% | 12.2% | 19.2% | 10.6% | 1.9% | 16.3% | 18.2% | 13.2% | 10.6% | 18.4% | 20.0% |
| Other income | 16 Cr | 15 Cr | 30 Cr | 28 Cr | 24 Cr | 33 Cr | 37 Cr | 19 Cr | 14 Cr | 16 Cr | 47 Cr | 89 Cr |
| Interest | 4 Cr | 3 Cr | 5 Cr | 4 Cr | 3 Cr | 4 Cr | 6 Cr | 5 Cr | 4 Cr | 5 Cr | 6 Cr | 4 Cr |
| Depreciation | 12 Cr | 15 Cr | 16 Cr | 22 Cr | 14 Cr | 15 Cr | 34 Cr | 27 Cr | 14 Cr | 15 Cr | 38 Cr | 50 Cr |
| Profit before tax | 306 Cr | 124 Cr | 105 Cr | 316 Cr | 190 Cr | 34 Cr | 168 Cr | 335 Cr | 200 Cr | 113 Cr | 206 Cr | 402 Cr |
| Tax % | 27.1% | 25.0% | 8.9% | 19.5% | 28.3% | -1.8% | 14.7% | 16.9% | 23.8% | 15.3% | 21.5% | 20.0% |
| Net profit | 223 Cr | 93 Cr | 96 Cr | 254 Cr | 136 Cr | 34 Cr | 143 Cr | 279 Cr | 153 Cr | 96 Cr | 162 Cr | 322 Cr |
| EPS (₹) | ₹49.60 | ₹20.72 | ₹21.36 | ₹56.56 | ₹30.33 | ₹7.61 | ₹31.88 | ₹62.01 | ₹33.98 | ₹21.29 | ₹36.07 | ₹71.56 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,948 Cr | 2,749 Cr | 2,686 Cr | 3,609 Cr | 4,261 Cr | 4,734 Cr | 5,140 Cr | 5,103 Cr | 5,473 Cr | 5,675 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 2,535 Cr | 2,340 Cr | 2,313 Cr | 2,883 Cr | 3,450 Cr | 3,923 Cr | 4,216 Cr | 4,149 Cr | 4,784 Cr | 4,801 Cr | Sign in free for the trailing twelve months |
| EBITDA | 414 Cr | 409 Cr | 373 Cr | 726 Cr | 812 Cr | 811 Cr | 924 Cr | 954 Cr | 690 Cr | 874 Cr | Sign in free for the trailing twelve months |
| OPM % | 14.0% | 14.9% | 13.9% | 20.1% | 19.0% | 17.1% | 18.0% | 18.7% | 12.6% | 15.4% | Sign in free for the trailing twelve months |
| Other income | 70 Cr | 39 Cr | 37 Cr | 66 Cr | 64 Cr | 55 Cr | 64 Cr | 81 Cr | 120 Cr | 95 Cr | Sign in free for the trailing twelve months |
| Interest | 7 Cr | 11 Cr | 10 Cr | 14 Cr | 13 Cr | 13 Cr | 22 Cr | 20 Cr | 17 Cr | 20 Cr | Sign in free for the trailing twelve months |
| Depreciation | 29 Cr | 33 Cr | 34 Cr | 65 Cr | 74 Cr | 65 Cr | 80 Cr | 74 Cr | 85 Cr | 94 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 448 Cr | 404 Cr | 366 Cr | 583 Cr | 795 Cr | 847 Cr | 990 Cr | 941 Cr | 707 Cr | 855 Cr | Sign in free for the trailing twelve months |
| Tax % | 35.0% | 25.7% | 35.1% | 18.6% | 37.9% | 23.8% | 23.4% | 21.3% | 19.7% | 19.4% | Sign in free for the trailing twelve months |
| Net profit | 291 Cr | 300 Cr | 238 Cr | 475 Cr | 493 Cr | 645 Cr | 758 Cr | 741 Cr | 568 Cr | 689 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹82.31 | ₹86.16 | ₹69.20 | ₹105.58 | ₹109.72 | ₹143.58 | ₹168.71 | ₹164.77 | ₹126.38 | ₹153.35 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 104.6% | 104.3% | 74.0% | 81.9% | 98.7% | 81.7% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 35 Cr | 34 Cr | 34 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr |
| Reserves | 2,021 Cr | 1,744 Cr | 1,849 Cr | 2,528 Cr | 2,505 Cr | 2,479 Cr | 2,667 Cr | 2,805 Cr | 2,806 Cr | 2,921 Cr |
| Borrowings | — | — | — | 2 Cr | — | — | — | — | — | — |
| Other liabilities | 769 Cr | 757 Cr | 1,018 Cr | 1,262 Cr | 1,689 Cr | 1,829 Cr | 1,967 Cr | 1,748 Cr | 2,396 Cr | 2,734 Cr |
| Total liabilities | 2,825 Cr | 2,535 Cr | 2,902 Cr | 3,836 Cr | 4,239 Cr | 4,353 Cr | 4,679 Cr | 4,597 Cr | 5,246 Cr | 5,699 Cr |
| Fixed assets (net) | 305 Cr | 300 Cr | 293 Cr | 436 Cr | 393 Cr | 437 Cr | 428 Cr | 376 Cr | 427 Cr | 402 Cr |
| CWIP | 1 Cr | 1 Cr | 0.70 Cr | 4 Cr | 8 Cr | 13 Cr | 3 Cr | 6 Cr | 0.50 Cr | 5 Cr |
| Investments | 50 Cr | — | 381 Cr | 71 Cr | 82 Cr | 65 Cr | 67 Cr | 79 Cr | 60 Cr | 82 Cr |
| Inventories | 768 Cr | 740 Cr | 878 Cr | 964 Cr | 1,325 Cr | 1,512 Cr | 1,807 Cr | 1,545 Cr | 2,362 Cr | 2,136 Cr |
| Trade receivables | 557 Cr | 659 Cr | 594 Cr | 718 Cr | 755 Cr | 1,005 Cr | 976 Cr | 960 Cr | 952 Cr | 1,116 Cr |
| Cash & bank | 838 Cr | 417 Cr | 327 Cr | 1,067 Cr | 1,205 Cr | 781 Cr | 861 Cr | 1,157 Cr | 886 Cr | 1,415 Cr |
| Other assets | 307 Cr | 418 Cr | 429 Cr | 576 Cr | 472 Cr | 540 Cr | 537 Cr | 473 Cr | 559 Cr | 546 Cr |
| Total assets | 2,825 Cr | 2,535 Cr | 2,902 Cr | 3,836 Cr | 4,239 Cr | 4,353 Cr | 4,679 Cr | 4,597 Cr | 5,246 Cr | 5,699 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 157 Cr | 121 Cr | 402 Cr | 666 Cr | 687 Cr | 216 Cr | 609 Cr | 952 Cr | 262 Cr | 1,079 Cr |
| Cash from investing | -8 Cr | 38 Cr | -412 Cr | -29 Cr | 7 Cr | 64 Cr | 83 Cr | 0.40 Cr | 86 Cr | 73 Cr |
| Cash from financing | -73 Cr | -581 Cr | -79 Cr | -148 Cr | -556 Cr | -703 Cr | -613 Cr | -656 Cr | -619 Cr | -624 Cr |
| Net cash flow | 76 Cr | -421 Cr | -90 Cr | 489 Cr | 138 Cr | -424 Cr | 80 Cr | 296 Cr | -271 Cr | 529 Cr |
| Free cash flow (OCF − Capex) | 102 Cr | 78 Cr | 357 Cr | 625 Cr | 645 Cr | 160 Cr | 532 Cr | 906 Cr | 221 Cr | 1,014 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 22.1% | 23.3% | 20.0% | 23.2% | 31.6% | 34.1% | 37.3% | 33.7% | 25.4% | 29.5% |
| ROE % | 14.1% | 16.9% | 12.6% | 18.4% | 19.3% | 25.6% | 28.0% | 26.0% | 19.9% | 23.2% |
| Debtor days | 69 | 87 | 80 | 73 | 64 | 77 | 69 | 69 | 63 | 72 |
| Inventory days | 176 | 220 | 231 | 201 | 194 | 213 | 259 | 207 | 240 | 247 |
| Days payable | 66 | 84 | 131 | 99 | 122 | 116 | 125 | 81 | 111 | 143 |
| Cash conversion cycle | 179 | 223 | 180 | 174 | 137 | 175 | 203 | 195 | 192 | 175 |
| OCF / EBITDA % | 38.0% | 29.7% | 107.7% | 91.7% | 84.6% | 26.6% | 65.9% | 99.7% | 38.0% | 123.4% |
| OCF / EBITDA % (3 years) | — | — | 56.9% | 78.8% | 91.8% | 66.8% | 59.3% | 66.1% | 71.0% | 91.1% |
| Debt / equity | — | — | — | 0.0006 | 0.00 | — | — | — | — | — |
| Current ratio | 3.48 | 3.14 | 2.31 | 2.65 | 2.26 | 2.15 | 2.19 | 2.44 | 2.01 | 1.92 |
| Net debt / EBITDA | -2.03 | -1.02 | -0.88 | -1.47 | -1.48 | -0.96 | -0.93 | -1.21 | -1.28 | -1.62 |